David A Lindholm

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 127 citations · Full text

Long Covid, Clinical Therapeutic, Covid-19 Pandemic +6

SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies

Sabrina Lusvarghi, Simon Pollett, Sabari Nath Neerukonda et al. · Science Translational Medicine · 2022 · 94 citations · Full text

Immunology, Spike Gene, Sars-cov-2 Ba.1 Variant +16

Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection

Stephanie A Richard, Simon Pollett, Anthony C Fries et al. · JAMA Network Open · 2023 · 88 citations · Full text

Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history

Wei Wang, Sabrina Lusvarghi, Rahul Subramanian et al. · Cell Host & Microbe · 2022 · 70 citations · Full text

Understanding “Hybrid Immunity”: Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines

Nusrat J Epsi, Stephanie A Richard, David A Lindholm et al. · Clinical Infectious Diseases · 2022 · 57 citations · Full text

Humoral Immune Responses, Immunodeficiencies, Humoral Response +19